𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Abnormal cervicovaginal cytology with negative human papillomavirus testing

✍ Scribed by Negri, Giovanni ;Rigo, Bettina ;Vittadello, Fabio ;Mian, Christine ;Egarter-Vigl, Eduard


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
74 KB
Volume
111
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background:

Human papillomavirus (hpv) testing has become part of cervicovaginal diagnostics in many laboratories. false-negative hpv results, even if rare, are potentially relevant clinically, particularly when testing is used alone. in this study, the authors investigated the occurrence and causes of abnormal cervicovaginal cytologies with negative hpv testing.

Methods:

The study was performed on 4130 liquid-based cytology (lbc) specimens from 2918 women who had abnormal cervical cytology or colposcopy or a history of abnormal cervical smear. hpv testing with hybrid capture ii was repeated in lbc specimens with obviously atypical cytology (squamous intraepithelial lesion or abnormal squamous cells, cannot exclude high-grade lesion) and initial negative test results. the results were compared with the follow-up results and with the cytologic features of the specimens.

Results:

Of 4130 lbc specimens, 94 (2.28%) showed obviously abnormal cells despite negative hpv results, and 50 of those 94 samples (53.19%) were hpv-positive on a repeated testing of the same specimen. histologic follow-up showed high-grade intraepithelial lesion or carcinoma in 10 specimens that initially were negative for hpv. eight of those samples were hpv-positive on testing repetition. both specimens that had persistently negative results had poor-quality cytologic samples at revision.

Conclusions:

High-grade lesions may be identified in the follow-up of hpv-negative specimens with abnormal cytology. testing repetition in patients with discordant cytology may prevent most potentially clinically relevant false-negative hpv results.


πŸ“œ SIMILAR VOLUMES


Integration of human papillomavirus vacc
✍ Schiffman, Mark πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 405 KB

There is justifiable excitement about the recent introduction of prophylactic vaccines against human papillomavirus (HPV) types 16 (HPV-16) and HPV-18. Preventing these infections theoretically could avert approximately 70% of cervical cancer cases worldwide. In the U.S., numerous influential advoca

Predictors of human papillomavirus persi
✍ Delphine Maucort-Boulch; Martyn Plummer; Philip E. Castle; Franklin Demuth; Mahb πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 209 KB

## Abstract We investigated short‐term persistence of human papillomavirus (HPV) infection among 2,408 women with low‐grade or equivocal cytological abnormalities followed for 24 months. Odds ratios (ORs) for persistence to the next 6‐month visit were estimated by a discrete time survival model. Pr

Absolute risk of a subsequent abnormal p
✍ Philip E. Castle; Sholom Wacholder; Mark E. Sherman; Attila T. Lorincz; Andrew G πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Abstract ## BACKGROUND The addition of human papillomavirus (HPV) DNA testing to cytologic screening for cervical carcinoma is now being considered. The majority of women in screening cohorts who test positive for oncogenic types of HPV DNA have concurrent negative Pap tests. The absolute risk

Human papillomavirus infection among wom
✍ Marinko Dobec; Fridolin Bannwart; Sandra Kilgus; Franz Kaeppeli; Pascal Cassinot πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 1 views

## Abstract Limited data are available describing human papillomavirus (HPV) genotype distribution among females with cytological abnormalities in Switzerland. Cervical cell specimens obtained from 5,318 women were screened routinely by liquid‐based Pap smear. All specimens with cellular abnormalit